IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL)
2 Visualizzazioni
• 07/02/23
0
0
Incorporare
administrator
Iscritti
In this month’s “Hot Topic,” Dr. Curt Hanson will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53 sequencing in these patients.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti